Abstract
Letters15 January 1997Prevention of Venous Thrombosis in Knee ArthroplastyJacques R. Leclerc, MDJacques R. Leclerc, MDLilly Corporate Center, Indianapolis, IN 46285Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-126-2-199701150-00020 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Drs. Basskin and Jacobson raise important points about our study. Investigators in one contemporary trial, which compared enoxaparin with placebo after major knee surgery, obtained a 60% rate of total deep venous thrombosis in patients who received placebo [1]. These results indicate that deep venous thrombosis is an ongoing problem despite improved surgical care and early patient ambulation.Compliance with enoxaparin was not a major issue in our trial because enoxaparin was administered by the nursing staff during hospitalization.We did not do subgroup analyses for age, mobility status, or other variables. Most of our patients were able ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
